A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Dylan Domenico et al.|Clinical Cancer Research|2023Cited by 34
Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet ProductionJohn Mascarenhas, Ronald Hoffman, Heidi Kosiorek et al.|Blood|2021Cited by 16
Supplementary Table S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2023Cited by 0
Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2023Cited by 0
Supplementary Figure S5 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2024Cited by 0